Serology as an early diagnostic tool in pediatric patients with Shiga toxin-producing Escherichia coli -associated hemolytic uremic syndrome: a post hoc analysis of a phase 2 clinical trial

Stella Maris Landivar; Luciano J. Melli; Mariana Pichel; Marta Rivas; Mariana Colonna; Carolina Massa; Vanesa Zylberman; Santiago Sanguineti; Linus Spatz; Fernando A. Goldbaum; Diego J. Comerci; Juan E. Ugalde; Andrés E. Ciocchini; INM004 Study Group; Alicia Fayad; Silvia Consolo; Alejandro Balestracci; Laura Alconcher; Lidia Ghezzi; Oscar Amoreo; María Carolina Bettendorff; María Valeria Blumetti; Pablo Bonany; Luis Flynn; Jorge Montero; Claudia Seminara; Ángela Suárez; Ana Paula Spizzirri

doi:10.1128/jcm.01415-25

Key Points

To evaluate the effectiveness of serology as an early diagnostic tool for hemolytic uremic syndrome in pediatric patients.
Conducted a post hoc analysis of a phase 2 clinical trial.
Examined pediatric patients diagnosed with hemolytic uremic syndrome.
Utilized serological testing to assess diagnosis accuracy.
Serology demonstrated a strong predictive value for diagnosing hemolytic uremic syndrome.
Early detection through serology may improve management outcomes in affected children.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Post hoc analysis demonstrates the effectiveness of serology in diagnosing pediatric hemolytic uremic syndrome, suggesting improved early detection strategies.

Abstract

This study was registered with ClinicalTrials.gov as NCT05569746.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Landivar et al. (2026) studied this question.

synapsesocial.com/papers/69a3d8caec16d51705d3000c https://doi.org/10.1128/jcm.01415-25

View Full Paper

Ask AI

Bookmark

Share

Serology as an early diagnostic tool in pediatric patients with Shiga toxin-producing Escherichia coli -associated hemolytic uremic syndrome: a post hoc analysis of a phase 2 clinical trial

Key Points

No abstract yet

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Serology as an early diagnostic tool in pediatric patients with Shiga toxin-producing Escherichia coli -associated hemolytic uremic syndrome: a post hoc analysis of a phase 2 clinical trial

Key Points

No abstract yet

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading